Establishment of CRISPR/Cas9-edited LEMD2 knock-in (UKWCHFi001-B-1) and knock-out (UKWCHFi001-B-2) iPSC lines to investigate the mechanisms of LEMD2-associated cardiomyopathy

Stem Cell Research · Published 2026-06-26 · DOI 10.1016/j.scr.2026.104049

Free full text

Authors (4)

Simone Buchmann, Anna Aldinger, Eva Klopocki, Brenda Gerull

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Buchmann, S., Aldinger, A., Klopocki, E., et al. (2026). Establishment of CRISPR/Cas9-edited LEMD2 knock-in (UKWCHFi001-B-1) and knock-out (UKWCHFi001-B-2) iPSC lines to investigate the mechanisms of LEMD2-associated cardiomyopathy. Stem Cell Research. https://doi.org/10.1016/j.scr.2026.104049

Related articles